Latest News & Updates
Breaking News
3 hours ago
Pharma Now Editorial Team
Pharma Now Editorial Team
Pharma Now Editorial Team
Pharma Now Editorial Team
Pharma Now Editorial Team
Other trending news you may like to read
Regeneron Signs $2.32 Billion Deal with Parabilis for Helicon Peptide-Antibody Conjugates
Regeneron's $2.32B Parabilis deal brings Helicon peptide-antibody conjugates into GMP scope, raising new CMC and manufacturing challenges for the conjugate space.
Pharma Now Editorial Team
Apothecon Pharma Appoints Shyamakant Giri as Group CEO to Lead India-US Operations
Apothecon Pharma names Shyamakant Giri Group CEO to unify strategy across its India and US operations, including Navinta LLC.
Pharma Now Editorial Team
Monopar Publishes Phase 2 Data Showing ALXN1840 Improves Copper Balance in Wilson Disease Patients
Monopar's Phase 2 data in Hepatology Communications show ALXN1840 significantly improves copper balance in Wilson disease, reinforcing Phase 3 findings.
Pharma Now Editorial Team
Eton Pharmaceuticals Secures U.S. Commercialization Rights to IMPAVIDO from Knight Therapeutics
Eton Pharmaceuticals takes U.S. commercialization of IMPAVIDO® (miltefosine) from Knight Therapeutics, effective September 26, 2026.
Pharma Now Editorial Team
